NCT03377374View on ClinicalTrials.gov

L. Reuteri ATCC PTA 5289 & L. Reuteri DSM 17938 for the Treatment of Children With Pharyngitis and/or Tonsillitis

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 28, 2017

Primary Completion Date

May 30, 2018

Study Completion Date

February 11, 2019

Conditions
PharyngitisTonsillitis
Interventions
DIETARY_SUPPLEMENT

Probiotic

L. reuteri Prodentis oil drops (L. reuteri DSM 17938 and L. reuteri ATCC PTA 5289) will be given at a dose of 2x108 Colony Forming Units (CFU). Five drops are to be taken twice a day (in the morning and in the evening) giving a daily dose of 4x108 CFU/day.

OTHER

Placebo

Five drops of Placebo taken twice a day (in the morning and in the evening).

Trial Locations (1)

14080

Hospital General Dr. Manuel Gea Gonzalez, Mexico City

All Listed Sponsors
lead

Innovacion y Desarrollo de Estrategias en Salud

OTHER

NCT03377374 - L. Reuteri ATCC PTA 5289 & L. Reuteri DSM 17938 for the Treatment of Children With Pharyngitis and/or Tonsillitis | Biotech Hunter | Biotech Hunter